Investors |

Media

LexaGene in Forbes: Positioned to fight coronavirus pandemic

Forbes profile on LexaGene’s technology: ‘It’s hard to imagine a startup better positioned to respond to the coronavirus pandemic than Beverly, Massachusetts-based LexaGene.’

Read More

Boston Herald logo

Dr. Regan quoted in Boston Herald

Dr. Jack Regan, CEO and Founder of LexaGene quoted in Boston Herald article on the potential resurgence of COVID-19 in the fall.

Read More

Jack Regan in LexaGene lab

LexaGene featured in Clinical Lab Products

LexaGene featured in Clinical Lab Products: “LexaGene responds to demand for better diagnostics for COVID-19.”

Read More

Boston Herald logo

LexaGene talks COVID with Boston Herald

LexaGene featured in Boston Herald: “Testing for the coronavirus could be done in an hour without lab-trained technicians using a device the size of a Keurig coffee machine that a Boston-area biotech company is developing.”

Read More

LexaGene on ABC News

LexaGene featured on ABC affiliate WCVB News Boston on how the company plans to help with better testing for the rapid detection of COVID-19.

Watch now

New York Times logo

LexaGene in New York Times

LexaGene mentioned in New York Times article focusing on genomic testing efforts to combat COVID-19.

Read More

LexaGene mentioned in Forbes on COVID-19

LexaGene CEO Dr. Jack Regan mentioned in Forbes article on the potential infection rate of COVID-19 and worldwide impact.

Read More

LexaGene local coverage: Coronavirus

Read local coverage of LexaGene’s development of a genetic analyzer to detect viruses like coronavirus.

Read More

Coronavirus news recap

LexaGene CEO and Founder Dr. Jack Regan explains the threat of the current coronavirus outbreak and recaps LexaGene’s latest news describing the company’s role in preventing the spread of pathogens like coronavirus.

Watch now

Cleanroom Technology article

Shortcomings in traditional culture testing leave the cannabis industry in search of methods that can enumerate or count the presence of microbes whether dead or alive. LexaGene CEO Dr. Jack Regan presents an alternative in the Cleanroom Technology article on LexaGene’s DNA-driven pathogen detection for cannabis-hemp products.

Read More

Forbes features LexaGene: Next big breakthrough

This Forbes full-length feature on LexaGene and our technology describes how LexaGene could be the next big medical breakthrough. > Read now.

Read More

LexaGene introduced in Forbes

LexaGene was mentioned in this Forbes article as a solution provider tackling the challenge of improving food safety and reducing recalls.

Read More